Emerging in the arena of weight management management, retatrutide represents a unique method. Beyond many current medications, retatrutide functions as a dual agonist, simultaneously targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic substance (GIP) binding sites. This concurrent engagement fosters various advantag